Next-generation sequencing has revolutionized genetic analysis of solid tumors, leading to more effective and less harmful therapies. Despite its benefits, there are opportunities for improvements to serve clinical labs and patients better.
The clinical need for faster turnaround times
Effects of sample quality and quantity on patients
The costs associated with complex workflows
![]()
Access the Infographic
Complete the form to download this informative infographic, Improving Patient Outcomes Begins with Tumor Profiling.
As comprehensive genomic analyses become increasingly available, healthcare professionals face challenges introduced by complex technology. Optimizing multiplexing technology that improves turnaround time, lowers QNS rates, and simplifies testing workflows are critical for improving cancer patient outcomes. Complete the form above to learn more.